Works matching DE "ANTIBODY-drug conjugates"
Results: 1241
Novel Concepts in Radioimmunotherapy for Non-Hodgkin's Lymphoma.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 2, p. 203
- By:
- Publication type:
- Article
Site‐Selective Protein Conjugation by a Multicomponent Ugi Reaction.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 14, p. 1, doi. 10.1002/chem.202303242
- By:
- Publication type:
- Article
Fast Cysteine Bioconjugation Chemistry.
- Published in:
- Chemistry - A European Journal, 2022, v. 28, n. 66, p. 1, doi. 10.1002/chem.202201843
- By:
- Publication type:
- Article
Antibody‐Drug‐Conjugate Therapy for Hematological Cancers: Matching Cell Biology with Clinical Benefit.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 44, p. 1, doi. 10.1002/adfm.202100032
- By:
- Publication type:
- Article
Pro-metastatic functions of lipoproteins and extracellular vesicles in the acidic tumor microenvironment.
- Published in:
- Cancer & Metastasis Reviews, 2019, v. 38, n. 1/2, p. 79, doi. 10.1007/s10555-019-09786-5
- By:
- Publication type:
- Article
Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2019, v. 257, n. 8, p. 1771, doi. 10.1007/s00417-019-04337-8
- By:
- Publication type:
- Article
Nanotechnology: Deliver on a promise.
- Published in:
- Nature, 2014, v. 509, n. 7502, p. S58, doi. 10.1038/509S58a
- By:
- Publication type:
- Article
Toxic antibodies blitz tumours.
- Published in:
- Nature, 2011, v. 476, n. 7361, p. 380, doi. 10.1038/476380a
- By:
- Publication type:
- Article
Synthesis of Conjugates of Lupane-Type Pentacyclic Triterpenoids with 2-Aminoethane- and N-Methyl-2-Aminoethanesulfonic Acids. Assessment of in vitro Toxicity.
- Published in:
- Chemistry of Natural Compounds, 2017, v. 53, n. 5, p. 907, doi. 10.1007/s10600-017-2153-6
- By:
- Publication type:
- Article
Conjugates of several lupane, oleanane, and ursane triterpenoids with the antituberculosis drug isoniazid and pyridinecarboxaldehydes.
- Published in:
- Chemistry of Natural Compounds, 2011, v. 47, n. 5, p. 752, doi. 10.1007/s10600-011-0050-y
- By:
- Publication type:
- Article
A Case of Enfortumab Vedotin-Associated Diabetic Ketoacidosis With Severe Insulin Resistance in a Nondiabetic Woman.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 12, p. 1, doi. 10.1210/jcemcr/luae212
- By:
- Publication type:
- Article
Small Molecule-Drug Conjugates: Targeted Tunable Therapy for Cancer Treatment.
- Published in:
- International Journal of High School Research, 2024, v. 6, n. 12, p. 77, doi. 10.36838/v5i1.15
- By:
- Publication type:
- Article
Trastuzumab Deruxtecan for the Treatment of HER2-low Advanced or Metastatic Breast Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 1, p. 36, doi. 10.17925/ohr.2024.20.1.8
- By:
- Publication type:
- Article
Sacituzumab Govitecan for the Treatment of HR+/HER2-Breast Cancer in Heavily Pre-treated Patients.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 2, p. 12, doi. 10.17925/OHR.2023.19.1.1
- By:
- Publication type:
- Article
The Evolving Therapeutic Landscape and Role of Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Systematic Review.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 27, doi. 10.17925/OHR.2023.19.1.27
- By:
- Publication type:
- Article
Trastuzumab Deruxtecan for the Treatment of HER2-positive Breast Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 6, doi. 10.17925/OHR.2023.19.1.6
- By:
- Publication type:
- Article
Pneumococcal Conjugate Vaccine Shortage Resolved.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2004, v. 53, n. 36, p. 851
- Publication type:
- Article
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-07439-0
- By:
- Publication type:
- Article
Submerged fermentation of Streptomyces uncialis providing a biotechnology platform for uncialamycin biosynthesis, engineering, and production.
- Published in:
- Journal of Industrial Microbiology & Biotechnology, 2021, v. 48, n. 3/4, p. 1, doi. 10.1093/jimb/kuab025
- By:
- Publication type:
- Article
Submerged fermentation of Streptomyces uncialis providing a biotechnology platform for uncialamycin biosynthesis, engineering, and production.
- Published in:
- Journal of Industrial Microbiology & Biotechnology, 2021, p. 1, doi. 10.1093/jimb/kuab025
- By:
- Publication type:
- Article
Early-stage breast cancer: Update on management.
- Published in:
- Medicine Today, 2024, v. 25, n. 3, p. 45
- By:
- Publication type:
- Article
Myristic acid-conjugated polyethylenimine for brain-targeting delivery: in vivo and ex vivo imaging evaluation.
- Published in:
- Journal of Drug Targeting, 2010, v. 18, n. 6, p. 438, doi. 10.3109/10611860903494229
- By:
- Publication type:
- Article
Dual potency anti-HER2/neu and anti-EGFR anthracycline immunoconjugates in chemotherapeutic-resistant mammary carcinoma combined with cyclosporin A and verapamil P-glycoprotein inhibition.
- Published in:
- Journal of Drug Targeting, 2009, v. 17, n. 6, p. 474, doi. 10.1080/10611860903012802
- By:
- Publication type:
- Article
Immunoconjugates: Current Status and Future Potential.
- Published in:
- 2002
- By:
- Publication type:
- Editorial
Therapeutic approach in a young woman with aggressive triple-negative breast cancer – case report.
- Published in:
- Oncolog-Hematolog, 2024, v. 69, n. 4, p. 47
- By:
- Publication type:
- Article
Real-world data of HER2-positivity spectrum in patients with breast cancer in Romania (SPECTRUM).
- Published in:
- Oncolog-Hematolog, 2024, v. 69, n. 4, p. 41
- By:
- Publication type:
- Article
New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 54, doi. 10.3390/vaccines12010054
- By:
- Publication type:
- Article
Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1111, doi. 10.3390/vaccines9101111
- By:
- Publication type:
- Article
Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 882, doi. 10.3390/vaccines9080882
- By:
- Publication type:
- Article
Cell-penetrating peptides improve pharmacokinetics and pharmacodynamics of anticancer drugs.
- Published in:
- Tissue Barriers, 2022, v. 10, n. 1, p. 1, doi. 10.1080/21688370.2021.1965418
- By:
- Publication type:
- Article
Real-time ultrasound elastography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 9, p. 1628
- By:
- Publication type:
- Article
Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Design considerations of an IL13Rα2 antibody–drug conjugate for diffuse intrinsic pontine glioma.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01184-9
- By:
- Publication type:
- Article
Design considerations of an IL13Rα2 antibody–drug conjugate for diffuse intrinsic pontine glioma.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01184-9
- By:
- Publication type:
- Article
An Anti-CD7 Antibody–Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leukemia (T-ALL).
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 1, p. 106, doi. 10.3390/biom14010106
- By:
- Publication type:
- Article
Race for the Cure: From the Oldest to the Newest Monoclonal Antibodies for Multiple Myeloma Treatment.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 8, p. 1146, doi. 10.3390/biom12081146
- By:
- Publication type:
- Article
Uncovering therapeutic opportunities in the clinical development of antibody‐drug conjugates.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 9, p. 1, doi. 10.1002/ctm2.1329
- By:
- Publication type:
- Article
Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb‐202 in gastric cancer.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 6, p. 1, doi. 10.1002/ctm2.454
- By:
- Publication type:
- Article
Adverse events caused by drug interactions involving glucuronoconjugates of zidovudine, valproic acid and lamotrigine, and analysis of how such potential events are discussed in package inserts of Japan, UK and USA.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2007, v. 32, n. 2, p. 177, doi. 10.1111/j.1365-2710.2007.00814.x
- By:
- Publication type:
- Article
Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1301437
- By:
- Publication type:
- Article
Antibody-drug conjugates in urinary tumors: clinical application, challenge, and perspectives.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2023.1259784
- By:
- Publication type:
- Article
A narrative review of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1252652
- By:
- Publication type:
- Article
Triple-negative breast cancer: from none to multiple therapeutic targets in two decades.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1244781
- By:
- Publication type:
- Article
Targeting STEAP1 as an anticancer strategy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1285661
- By:
- Publication type:
- Article
Assessing real-world safety concerns of Sacituzumab govitecan: a disproportionality analysis using spontaneous reports in the FDA adverse event reporting system.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1276976
- By:
- Publication type:
- Article
Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually?
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1254906
- By:
- Publication type:
- Article
Antibody-drug conjugates: the clinical development in gastric cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1211947
- By:
- Publication type:
- Article
Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1170394
- By:
- Publication type:
- Article
Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1161089
- By:
- Publication type:
- Article
Research trends and prospects on brain metastasis from breast cancer: A bibliometric analysis.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1091249
- By:
- Publication type:
- Article